Lynx1 Capital Management LP Q4 2025 Filing
Filed February 17, 2026
Portfolio Value
$494.0M
Holdings
22
Report Date
Q4 2025
Filing Type
13F-HR
All Holdings (22 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | STOKSTOKE THERAPEUTICS INC | 5,404,674 | $171.5M | 34.73% | |
| 2 | GHRSGH RESEARCH PLC | 10,406,575 | $132.2M | 26.75% | |
| 3 | CGEMCULLINAN THERAPEUTICS INC | 8,963,500 | $92.8M | 18.78% | |
| 4 | DNLIDENALI THERAPEUTICS INC | 1,738,750 | $28.7M | 5.81% | |
| 5 | CCCCC4 THERAPEUTICS INC | 7,098,133 | $13.6M | 2.74% | |
| 6 | XNCRXENCOR INC | 705,558 | $10.8M | 2.19% | |
| 7 | IMTXIMMATICS N.V | 921,950 | $9.7M | 1.96% | |
| 8 | TCRXTSCAN THERAPEUTICS INC | 8,019,148 | $8.0M | 1.62% | |
| 9 | PASGPASSAGE BIO INC | 623,704 | $7.4M | 1.49% | |
| 10 | KRROKORRO BIO INC | 677,915 | $5.4M | 1.10% | |
| 11 | DTILPRECISION BIOSCIENCES INC | 993,913 | $4.1M | 0.84% | |
| 12 | NEUPNEUPHORIA THERAPEUTICS INC | 875,228 | $3.4M | 0.69% | |
| 13 | AGIOAGIOS PHARMACEUTICALS INC | 79,624 | $2.2M | 0.44% | |
| 14 | CGONCG ONCOLOGY INC | 31,591 | $1.3M | 0.27% | |
| 15 | ARWRARROWHEAD PHARMACEUTICALS IN | 12,043 | $799K | 0.16% | |
| 16 | DSGNDESIGN THERAPEUTICS INC | 69,516 | $652K | 0.13% | |
| 17 | TRDAENTRADA THERAPEUTICS INC | 51,689 | $531K | 0.11% | |
| 18 | HOWLWEREWOLF THERAPEUTICS INC | 655,926 | $415K | 0.08% | |
| 19 | MPLTMAPLIGHT THERAPEUTICS INC | 13,477 | $236K | 0.05% | |
| 20 | GBIOGENERATION BIO CO | 25,000 | $142K | 0.03% | |
| 21 | PRQRPROQR THRAPEUTICS N V | 68,486 | $138K | 0.03% | |
| 22 | APLTAPPLIED THERAPEUTICS INC | 410,500 | $41K | 0.01% |